Targeting Age-Related Pathways in Heart Failure DOI Open Access
Haobo Li, Margaret H. Hastings, James Rhee

и другие.

Circulation Research, Год журнала: 2020, Номер 126(4), С. 533 - 551

Опубликована: Фев. 13, 2020

During aging, deterioration in cardiac structure and function leads to increased susceptibility heart failure. The need for interventions combat this age-related decline is becoming increasingly urgent as the elderly population continues grow. Our understanding of aging general, limited. However, recent studies its prevention through like exercise have revealed novel pathological cardioprotective pathways. In review, we summarize findings concerning molecular mechanisms failure highlight a valuable experimental platform discovery much-needed therapeutic targets chronic disease.

Язык: Английский

Cellular senescence and senolytics: the path to the clinic DOI Open Access
Selim Chaib, Tamar Tchkonia, James L. Kirkland

и другие.

Nature Medicine, Год журнала: 2022, Номер 28(8), С. 1556 - 1568

Опубликована: Авг. 1, 2022

Язык: Английский

Процитировано

626

The role of cellular senescence in ageing and endocrine disease DOI
Sundeep Khosla, Joshua N. Farr, Tamar Tchkonia

и другие.

Nature Reviews Endocrinology, Год журнала: 2020, Номер 16(5), С. 263 - 275

Опубликована: Март 11, 2020

Язык: Английский

Процитировано

398

Hypertension-induced cognitive impairment: from pathophysiology to public health DOI Open Access
Zoltán Ungvári, Péter Tóth, Stefano Tarantini

и другие.

Nature Reviews Nephrology, Год журнала: 2021, Номер 17(10), С. 639 - 654

Опубликована: Июнь 14, 2021

Язык: Английский

Процитировано

370

Mitochondrial dysfunction and cell senescence: deciphering a complex relationship DOI Open Access
James Chapman, Edward Fielder, João F. Passos

и другие.

FEBS Letters, Год журнала: 2019, Номер 593(13), С. 1566 - 1579

Опубликована: Июнь 18, 2019

Cellular senescence and mitochondrial dysfunction have both been defined as classical hallmarks of the ageing process. Here, we review intricate relationship between two. In context ageing, it is now well regarded that cellular a key driver in onset number age‐related pathologies. Emerging evidence has pinpointed mitochondria one modulators development phenotype, particularly pro‐inflammatory associated secretory phenotype (SASP). This focuses on contribution homeostatic mechanisms, reactive oxygen species metabolites programme. Furthermore, discuss emerging pathways mitochondrial‐mediated mechanisms may be influencing SASP and, subsequently, explore how these exploited to open up new therapeutic avenues.

Язык: Английский

Процитировано

261

Inflammation, Aging, and Cardiovascular Disease DOI Creative Commons
Luca Liberale, Lina Badimón, Fabrizio Montecucco

и другие.

Journal of the American College of Cardiology, Год журнала: 2022, Номер 79(8), С. 837 - 847

Опубликована: Фев. 21, 2022

Язык: Английский

Процитировано

246

Therapy-Induced Senescence: An “Old” Friend Becomes the Enemy DOI Open Access
Tareq Saleh, Sarah Bloukh,

Valerie J. Carpenter

и другие.

Cancers, Год журнала: 2020, Номер 12(4), С. 822 - 822

Опубликована: Март 29, 2020

For the past two decades, cellular senescence has been recognized as a central component of tumor cell response to chemotherapy and radiation. Traditionally, this form senescence, termed Therapy-Induced Senescence (TIS), was linked extensive nuclear damage precipitated by classical genotoxic chemotherapy. However, number other forms therapy have also shown induce in cells independently direct genomic damage. This review attempts provide comprehensive summary both conventional targeted anticancer therapeutics that vitro vivo. Still, utility promoting therapeutic endpoint remains under debate. Since represents durable growth arrest, it might be argued is desirable outcome cancer therapy. accumulating evidence suggesting capacity escape from TIS would support an alternative conclusion, provides avenue whereby can evade potentially lethal action drugs, allowing enter temporary state dormancy eventually facilitates disease recurrence, often more aggressive state. Furthermore, now strongly connected remodeling, dormancy, acquiring ominous malignant phenotypes accounts for several untoward adverse effects Here, we argue barrier effective treatment, discuss emerging efforts identify exploit agents with senolytic properties strategy elimination persistent residual surviving population, goal mitigating tumor-promoting influence senescent thereby reduce likelihood relapse.

Язык: Английский

Процитировано

225

The role of cellular senescence in cardiac disease: basic biology and clinical relevance DOI

Mozhdeh Mehdizadeh,

Martín Aguilar, Éric Thorin

и другие.

Nature Reviews Cardiology, Год журнала: 2021, Номер 19(4), С. 250 - 264

Опубликована: Окт. 19, 2021

Язык: Английский

Процитировано

182

Senolytics and senomorphics: Natural and synthetic therapeutics in the treatment of aging and chronic diseases DOI

Sofia M. Lagoumtzi,

Niki Chondrogianni

Free Radical Biology and Medicine, Год журнала: 2021, Номер 171, С. 169 - 190

Опубликована: Май 12, 2021

Язык: Английский

Процитировано

170

Senescence mechanisms and targets in the heart DOI Open Access
Maggie Chen, Richard Lee, Jessica C. Garbern

и другие.

Cardiovascular Research, Год журнала: 2021, Номер 118(5), С. 1173 - 1187

Опубликована: Май 5, 2021

Abstract Cellular senescence is a state of irreversible cell cycle arrest associated with ageing. Senescence different cardiac types can direct the pathophysiology cardiovascular diseases (CVDs) such as atherosclerosis, myocardial infarction, and fibrosis. While age-related telomere shortening represents major cause replicative senescence, senescent also be induced by oxidative stress, metabolic dysfunction, epigenetic regulation, among other stressors. It critical that we understand molecular pathways lead to cellular consequences in order develop new therapeutic approaches treat CVD. In this review, discuss mechanisms explore how (including cardiomyocytes, endothelial cells, fibroblasts, vascular smooth muscle valve interstitial cells) CVD, highlight potential target prevent or

Язык: Английский

Процитировано

169

Immune Clearance of Senescent Cells to Combat Ageing and Chronic Diseases DOI Creative Commons

Ping Song,

Junqing An,

Ming-Hui Zou

и другие.

Cells, Год журнала: 2020, Номер 9(3), С. 671 - 671

Опубликована: Март 10, 2020

Senescent cells are generally characterized by permanent cell cycle arrest, metabolic alteration and activation, apoptotic resistance in multiple organs due to various stressors. Excessive accumulation of senescent numerous tissues leads chronic diseases, tissue dysfunction, age-related diseases organ ageing. Immune can remove cells. Immunaging or impaired innate adaptive immune responses result persistent Although senolytics—drugs that selectively inducing their apoptosis—are recent hot topics making significant research progress, senescence immunotherapies using cell-mediated clearance emerging promising strategies fight ageing diseases. This short review provides an overview the progress date concerning cell-caused ageing, as well regulation small-molecule drugs clinical trials different roles elimination Mounting evidence indicates immunotherapy targeting combats subsequently extends healthy lifespan.

Язык: Английский

Процитировано

153